Skip to the page

Data / Drug companies / MSN Life Sciences Private Limited

MSN Life Sciences Private Limited: 121 products in the FDA NDC directory, labeler code 69766

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

MSN Life Sciences Private Limited (labeler code 69766) lists 121 products in the FDA National Drug Code Directory. By type: 121 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on March 30, 2026.

The request: Watch MSN Life Sciences Private Limited (FDA labeler code 69766): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
69766
Products in commercial distribution
121
Packages
144
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule IV 2, Schedule V 1
Started marketing in the last 12 months
3
Earliest marketing start
May 31, 2015
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients121100%

Products by type

TypeProductsShare
Bulk ingredients121100%

Dosage forms

Dosage formProductsShare
Powder12099.2%
Liquid10.8%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Ferric derisomaltose69766-124PowderBulk ingredientsMarch 30, 2026
Deutetrabenazine69766-123PowderBulk ingredientsMarch 7, 2026
Tirzepatide69766-122PowderBulk ingredientsFebruary 7, 2026
Iron dextran69766-120PowderBulk ingredientsMarch 13, 2025
Letermovir69766-119PowderBulk ingredientsJanuary 10, 2025
Sofosbuvir69766-118PowderBulk ingredientsJanuary 10, 2025
Candesartan cilexetil69766-083PowderBulk ingredientsDecember 31, 2024
Vigabatrin69766-117PowderBulk ingredientsSeptember 29, 2024
Metformin hydrochloride69766-116PowderBulk ingredientsSeptember 29, 2024
Difelikefalin acetate69766-115PowderBulk ingredientsSeptember 27, 2024
Isavuconazonium sulfate69766-113PowderBulk ingredientsMarch 28, 2024
Venlafaxine hydrochloride69766-114PowderBulk ingredientsMarch 26, 2024
Rimegepant sulfate69766-112PowderBulk ingredientsSeptember 29, 2023
Semaglutide69766-108PowderBulk ingredientsSeptember 23, 2023
Tenofovir alafenamide monofumarate69766-111PowderBulk ingredientsSeptember 7, 2023
Trazodone hydrochloride69766-110PowderBulk ingredientsAugust 31, 2023
Ubrogepant69766-109PowderBulk ingredientsAugust 22, 2023
Ferric carboxy maltose69766-093PowderBulk ingredientsMarch 24, 2023
Nirmatrelvir69766-105PowderBulk ingredientsDecember 30, 2022
Teduglutide69766-106PowderBulk ingredientsDecember 14, 2022
Ferumoxytol69766-104LiquidBulk ingredientsJuly 18, 2022
Regadenoson69766-103PowderBulk ingredientsNovember 24, 2021
Sincalide69766-102PowderBulk ingredientsOctober 30, 2021
Elagolix sodium69766-099PowderBulk ingredientsAugust 31, 2021
Irbesartan69766-101PowderBulk ingredientsJuly 30, 2021

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.